Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication.

• Tác giả: Douglas Arbetter, Silvia Boarino, David Cohen, Benjamin Emmanuel, Esther Garcia Gil, David J Jackson, Rohit Katial, Sheena Kayaniyil, Claudia Chaves Loureiro, Javier Nuevo, Alicia Padilla-Galo, Marisa Pardal, Girolamo Pelaia, Adrian Paul J Rabe, Anat Shavit, Vivian H Shih, Trung N Tran, Michael Watt
• Ngôn ngữ: eng
• Thông tin xuất bản: England : Immunotherapy , 2025
• Bộ sưu tập: NCBI
• ID: 52130